कृपया अन्य खोज का प्रयास करें
Emyria Limited, a clinical-stage biotech company, engages in the development of treatments for unmet medical needs. The company develops psychedelic-assisted therapy, as well as MDMA drug discovery program. Its drug development program includes EMD-RX5 for treatment of psychological distress and mild stress and anxiety. The company was formerly known as Emerald Clinics Limited and changed its name to Emyria Limited in September 2020. Emyria Limited was founded in 2018 and is headquartered in Leederville, Australia.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
David Putrino | - | - | Member of Medical Advisory Board |
Jennifer Morgan | - | - | Member of Medical Advisory Board |
Henry William Bosch | - | - | Member of Medical Advisory Board |
Mohit Kaushal | 44 | 2023 | Non-Executive Director |
Nik Zeps | - | - | Member of Medical Advisory Board |
Philip Finch | - | - | Member of Medical Advisory Board |
Richard Magtengaard | - | 2021 | Member of Medical Advisory Board |
John Edward Tooke | 74 | 2020 | Member of Medical Advisory Board & Independent Non-Executive Director |
Alistair Vickery | - | 2019 | Executive Medical Director & Director |
Michael Winlo | - | 2019 | MD & Director |
Karen L. Smith | 55 | 2021 | Non-Executive Director & Chairman of Strategic Advisory Board |
Greg Hutchinson | - | 2023 | Independent Non-Executive Chairman |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है